Association of C677T (rs1081133) and A1298C (rs1801131) Methylenetetrahydrofolate Reductase Variants with Breast Cancer Susceptibility Among Asians: A Systematic Review and Meta-Analysis by Moazzen, F et al.
Vol.:(0123456789)




Association of C677T (rs1081133) and A1298C (rs1801131) 
Methylenetetrahydrofolate Reductase Variants with Breast 
Cancer Susceptibility Among Asians: A Systematic Review 
and Meta‑Analysis
Maryam Rezaee, et al. [full author details at the end of the article]
Received: 22 July 2020 / Accepted: 28 November 2020 / Published online: 2 January 2021 
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021
Abstract
This systematic review and meta-analysis were conducted to investigate the asso-
ciation between methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C 
polymorphisms with breast cancer (BC) in Asians. Systematic searches were con-
ducted in PubMed, EMBASE, Web of Science, and Scopus by May 2020. Inter-
study heterogeneity was also assessed with a Q test, along with I2 statistics. Ran-
dom-effects models were applied to pooled crude ORs with corresponding 95% CIs 
for the genetic models. A total of 1097 identified results, along with 36 qualified 
studies were included: for MTHFR C677T polymorphism, a total of 36 studies was 
comprised of 11,261 cases and 13,318 controls and for MTHFR A1298C polymor-
phism, a number of 19 studies contained 7424 cases and 8204 controls. Likewise, 
for C677T polymorphism, an increased risk of BC was seen for the allelic (OR 1.21, 
95% CI 1.09–1.33, P < 0.01, I2 = 78.9%), dominant (OR 1.17, 95% CI 1.05–1.30, 
P < 0.01, I2 = 71.8%), recessive (OR 1.43, 95% CI 1.23–1.67, P < 0.01, I2 = 55.8%), 
and homozygous models (OR 1.48, 95% CI 1.25–1.75, P < 0.01, I2 59.9%) among 
BC patients compared to controls. Also, in terms of A1298C polymorphism, an 
association was found between the allelic (OR 1.15, 95% CI 1.04–1.28, P < 0.01, I2 
70.4%) and homozygous models (OR 1.38, 95% CI 1.15–1.66, P < 0.01, I2 44.2%) 
with the risk of BC. In conclusion, findings revealed that MTHFR C677T variant 
might be a factor that predisposes BC in Asians. Furthermore, it was found that 
A1298C variant acts as a BC risk factor, particularly in a Western Asia population.
Keywords Breast cancer · Methylenetetrahydrofolate reductase · Variant · 
Polymorphism · SNP
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Introduction
Considered as a major cause of death all over the world, breast cancer (BC) is 
seen as one of the most common malignancies among women, accounting for 
30% of all new cancer diagnoses. Moreover, although the malignancy is observed 
in both developed Western countries and developing Asian countries, BC is esti-
mated to have a higher mortality percentage in Asian countries than in West-
ern ones (Mubarik et  al. 2019; Paydar et  al. 2019). The reason for the higher 
rate of mortalities in these countries may be due to a variety of factors such as 
increased longevity, late diagnosis, insufficient access to care, higher exposure 
to risk factors, high-fat foods consumption, reduced pregnancy rates, and obesity 
(Ghoncheh et al. 2016; Yip 2009).
According to what was previously stated, the incidence of BC is intensified 
by hereditary and genetic factors. More than 170 genomic loci harboring com-
mon variants related to BC have been recognized by genome-wide association 
studies (GWAS). The most well known are mutations in the BRCAs genes (Fer-
reira et  al. 2019; Momenimovahed and Salehiniya 2019). Also, the mutation in 
methylenetetrahydrofolate reductase (MTHFR) has been shown to have a positive 
correlation with BC (Meneses-Sanchez et  al. 2019). Located on chromosome 1 
(p36.22), the MTHFR gene with 20.373 base pair contains 13 exons (Antonaros 
et al. 2019). This enzyme has been indicated to catalyze the irreversible conver-
sion of 5.10-methylenetetrahydrofolate (methyleneTHF) to 5-methyltetrahydro-
folate (methylTHF). The latter is involved in the conversion of homocysteine to 
methionine, thereby the formation of S-adenosylmethionine (SAM). Therefore, 
the MTHFR is involved in the methylation of DNA, indicating an association with 
cancer development (Odin et al. 2006). It has been shown that among the MTHFR 
mutations, C677T (rs1801133) and A1298C (rs1801131) are the most reported 
ones (Wan et  al. 2018). The C677T polymorphism (rs1801133) transforms ala-
nine into valine, resulting in reduced enzyme activity (Kumar et  al. 2015; Zhu 
et al. 2014). Numerous studies have revealed that the MTHFR C677T polymor-
phism is a risk factor for BC (Ergul et al. 2003; He and Shen 2017; Waseem et al. 
2016). As enzyme activity decreases by this mutation, the plasma levels of homo-
cysteine increase, as a result of which methylation of DNA reduces, hence the 
development of cancer (Waseem et al. 2016). However, other studies have shown 
contradictory results (Floris et  al. 2020; Hekim et  al. 2007; Kalyankumar and 
Jamil 2006). Another common SNP, A1298C (rs1801133), transforms glutamate 
to alanine at 429 residues and reduces enzyme activity (Wan et al. 2018). Similar 
to C677T, there is still controversy as to the association of this mutation with BC, 
particularly in Asian population (Castiglia et al. 2019; Kaya et al. 2016).
Given the higher rate of breast cancer among Asians and the contradictory 
results as to the role that MTHFR C677T and A1298C variants play in suscepti-
bility to BC among Asians, the aim of this systematic review and meta-analysis 
study was to investigate the role of MTHFR C677T and A1298C gene polymor-
phisms in BC in Asian populations.
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Methods
Literature Search
We ran a systematic search of electronic databases such as PubMed, EMBASE, Web 
of Science, Scopus, and Google Scholar in order to identify the related studies which 
investigated the association between MTHFR C677T and A1298C variants in an 
Asian population up to May 2020. The searches for the related literature were con-
ducted using a combination of the following MeSH terms and relevant keywords: 
"methylenetetrahydrofolate reductase (MTHFR)," "polymorphism," "genetic," 
"mutation," "point mutation," "mutation," "missense," "breast cancer," and "breast 
neoplasms" (Supp 1). To increase the comprehensiveness of our searches, we manu-
ally screened the references mentioned in the previous reviews and included arti-
cles. Searches were conducted in the English Language without any published date 
limitation.
Study Selection
Two researchers (SS and MM) carried out an independent review of the literature 
search results to select relevant studies based on our inclusion. It is worth noting 
that any disagreement was resolved through consensus and discussion. The studies 
that met the following inclusion criteria were selected for use in the meta-analysis: 
studies that investigated the association between MTHFR polymorphisms (including 
C677T and/or A1298C) and BC susceptibility were conducted with a non-familial, 
case–control design, reported sufficient genotype data or possessed the information 
to calculate the pooled OR and the corresponding 95% confidence intervals (CIs), 
and included participants who were from an Asian population. So, studies without 
usable data, with participants other than those of an Asian population, or with com-
bined ethnicities, having cases not confirmed by other approaches, and those lack-
ing full texts were excluded. When there were overlapping published studies, only a 
recent study with the most complete data for our meta-analysis was included.
Data Extraction
To achieve more precision, two researchers separately performed the extraction of 
data for all the eligible studies (SS and MM). The following items were extracted: 
first author’s name, year of publication, study location, ethnicity, participants’ 
descriptive characteristic, type of polymorphism, type of control, total sample size, 
and the number of alleles and genotypes in both case and control groups. A stand-
ardized data abstraction of Excel forms was used to extract the pertinent data.
Quality Assessment
The Newcastle–Ottawa Scale (NOS) was used to assess the quality of included stud-
ies. The following three domains were applied to critically evaluate each study: the 
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selection of case/control, comparability, and outcome. It is noteworthy that NOS 
scores ranged from 0 to 9 and that studies with scores of seven or more were consid-
ered as having a good quality.
Statistical Analysis
All the statistical analyses were conducted using STATA (version 11.0; Stata Corpo-
ration, College Station, TX). Crude odds ratios (ORs) with corresponding 95% CIs 
were estimated to investigate the strength of association between the MTHFR poly-
morphisms (includes C677T and/or A1298C) and BC susceptibility. With respect 
to C677T variant, genotypes were analyzed using genetic models such as the allelic 
(T vs. C), recessive (TT vs. CT + CC), dominant (TT + CT vs. CC), homozygote 
(TT vs. CC), heterozygous (CT vs. CC), and codominant models (CT vs. TT + CC). 
Likewise, A1298C genotypes were analyzed using the following genetic models: 
the allelic (C vs. A), recessive (CC vs. AC + AA), dominant (CC + AC vs. AA), 
homozygote (CC vs. AA), heterozygous (AC vs. AA), and codominant models (AC 
vs. CC + AA). Hardy–Weinberg Equilibrium (HWE) was used to assess the distribu-
tion of genotypes in the control group of each included study which has not devi-
ated from HWE by using the Chi-square test. Inter-study heterogeneity was evalu-
ated using the Cochran Q test and I2 statistic. It should be noted that a P < 0.1 for 
Q test and I2 greater than 50% showed a substantial heterogeneity. In the presence 
of heterogeneity, the random-effects model was used to pool the ORs and their 95% 
CIs, otherwise, the fixed-effect model was applied (P > 0.1 with I2 < 50%). Subgroup 
analyses were conducted to stratify the pooled findings based on the potential sus-
pected variables including ethnicity (Western Asia vs. Southern Asia vs. Eastern 
Asia), source of control (population base vs. hospital base vs. NI), genotyping (other 
techniques vs. PCR–RFLP), agreement with HWE (yes vs. no), and quality status 
(high vs. low) to explore the source of heterogeneity. Sensitivity analyses as an 
additional procedure were performed to assess the stability of the pooled ORs after 
excluding each study using the leave-one-out method and also to find the source 
of heterogeneity. Evidence of potential publication bias across included studies was 
quantitatively examined using Egger’s and Begg’s tests and funnel plot asymmetry 
was assessed visually.
Results
A total of 1097 studies were identified through comprehensive database searches. 
Out of all the screening studies, only a number of 36 qualified studies (Akilzhanova 
et al. 2006; Akram et al. 2012; Chou et al. 2006; DELIGEZER et al. 2005; Ergul 
et  al. 2003; He and Shen 2017; Hedayatizadeh-Omran et  al. 2017; Hekim et  al. 
2007; Hesari et al. 2019; Hosseini et al. 2011; Huang et al. 2014; Jiang-hua et al. 
2014; Kalyankumar and Jamil 2006; Kaya et al. 2016; Lajin et al. 2012; Lee et al. 
2004; Lin et al. 2004; Liu et al. 2013; Lu et al. 2015; Mir et al. 2008; Mohammadza-
deh et al. 2016; Naushad et al. 2011; Niu et al. 2017; Ozen et al. 2013; Pooja et al. 
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2015; Prasad and Wilkhoo 2011; Rahimi et al. 2019; Sangrajrang et al. 2010; Shrub-
sole et al. 2004; Song et al. 2016; Suzuki et al. 2008; Waseem et al. 2016; Weiner 
et al. 2010; Weiwei et al. 2014; Yu et al. 2007; Zhang et al. 2015) were found to be 
eligible based on inclusion criteria for the current meta-analysis. Figure 1 shows the 
flowchart of how the studies were identified and then selected step by step. A total of 
1097 studies were identified through comprehensive database searches.
The association between C677T polymorphism and BC was reported by 36 studies 
(containing 11,261 cases and 13,318 controls) and the association between A1298C 
polymorphism and BC was demonstrated by 19 studies (including 7424 cases and 8204 
controls). As the basic characteristics of the included studies are shown in Table 1, it 
was found that the genotype distributions of the controls were not in line with those of 
HWE in studies conducted by the He and Shen ( 2017), Weiwei et al. (2014), Hosseini 
et al. (2011), and Jiang-hua et al. (2014) with studies on C677T polymorphism and also 
by Akram et al. (2012), Ozen et al. (2013), Mir et al. (2008), Sangrajrang et al. (2010), 
(1097) publicaons were retrieved by searching the variant 
keywords of: “MTHFR or methylenetetrahydrofolate reductase” 
AND “C677T” AND “A1289C” AND “breast cancer” from PubMed, 
Web of science, EMBASE, and Google Scholar. Date of search: May 
22, 2020
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- Not English language= 6
- Nonhuman cell in vitro= 2
- Not a case-control study with case of 
breast cancer and control of healthy 
populaon= 10
- Not focused on breast cancer= 3
- Not focused on MTHFR= 9
- Not focused on MTHFR and breast 
cancer= 489
-not performed in Asia= 43
36 publicaons
Exclusion:
Insufficient data= 9 
Excluded duplicates:
(n= 344)
Fig. 1  The flowchart of, step by step, the study identification and selection process
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and studies on A1298C polymorphism. The included studies were published between 
2003 (Ergul et al. 2003) and 2019 (Rahimi et al. 2019).
Association of the MTHFR C677T Polymorphism with Breast Cancer Risk for Asians
The forest plots which represent the association of the C677T polymorphism with BC 
risk among an Asian population are shown in Fig. 2. The use of the random-effects 
model based on 36 qualified studies on the pooled results indicated that there was a 
significant association between genetic models including the allelic (OR 1.21, 95% CI 
1.09–1.33, P < 0.01, I2 = 78.9%), the dominant (OR 1.17, 95% CI 1.05–1.30, P < 0.01, 
I2 = 71.8%), the recessive (OR 1.43, 95% CI 1.23–1.67, P < 0.01, I2 = 55.8%), and 
the homozygous models (OR 1.48, 95% CI 1.25–1.75, P < 0.01, I2 = 59.9%) with an 
increased risk of BC among an Asian population, whereas the heterozygous (OR 1.08, 
95% CI 0.98–1.19, P = 0.11, I2 = 57.5%) and the codominant models (OR 0.98, 95% CI 
0.90–1.08, P = 0.72, I2  = 59.6%) did not reveal such a significant association.
According to the evidence of inter-study heterogeneity across the qualified studies 
(P < 0.01 with I2 > 50%), subgroup analyses were carried out according to moderator 
variables including ethnicity, source of control, genotyping, agreement with HWE, 
and quality status. With reference to Table 2, the results of the subgroups indicated the 
reduced heterogeneity in some of the strata. Meanwhile, it was found that there was a 
significant association between the all genetic models and the risk of BC in participants 
of Eastern Asia and hospital-based controls. Yet, the association between the codomi-
nant models and BC risk remained non-significant in different strata.
Following sensitivity analyses, the findings showed that after each study was 
removed, the pooled ORs for the allelic, dominant, recessive, homozygous, and codom-
inant models maintained their stability. However, the lower and higher pooled ORs 
in sensitivity analyses for these genetic models are presented in Table 3. But, for the 
heterozygous model, the sensitivity analysis results revealed that removal of a study 
conducted by Aklizhanova et  al. (2013) changed the pooled OR (OR 1.10, 95% CI 
1.00–1.20).
The funnel plot shapes of the genetic models were almost symmetrical, showing the 
lack of any evidence for publication bias (Supp 1 Fig. S1–S6). However, significant 
potential publication biases were statistically found using Begg and Egger’s tests for 
the recessive (P Begg’s test = 0.01, P Egger’s test = 0.04), and the homozygous models 
(P Begg’s test = 0.02, P Egger’s test = 0.06). After including the findings of censored 
studies using the trimming estimator with the linear method, there were no significant 
differences for these two genetic models in the pooled ORs between before and after 
the inclusion of censored studies.
Association of the MTHFR A1298C Polymorphism with Breast Cancer Risk 
for Asians
A number of 19 qualified studies examined the association between A1298C 
polymorphism and BC risk. It was found, using random-effects model, that the 
allelic (OR 1.15, 95% CI 1.04–1.28, P < 0.01, I2 = 70.4%) and the homozygous 
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NOTE: Weights are from random effects analysis




















































































































NOTE: Weights are from random effects analysis




















































































































Fig. 2  Forest plots of breast cancer risk associated with the MTHFR C677T polymorphism for the allelic 
(a), dominant (b), recessive (c), heterozygous (d), homozygous (e), codominant models (f)
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NOTE: Weights are from random effects analysis





















































































































NOTE: Weights are from random effects analysis




















































































































Fig. 2  (continued)
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models (OR 1.38, 95% CI 1.15–1.66, P < 0.01, I2 = 44.2%) were associated with 
the risk of BC among BC patients compared to controls; however, no such sig-
nificant association was seen between the dominant (OR 1.11, 95% CI 0.99–1.25, 
P = 0.068, I2 = 60.3%), recessive (OR 1.23, 95% CI 0.99–1.52, P = 0.065, 
I2 = 65.5%), heterozygous (OR 1.23, 95% CI 0.97–1.57, P = 0.085, I2 = 89.5%), 
E
NOTE: Weights are from random effects analysis




















































































































NOTE: Weights are from random effects analysis



















































































































Fig. 2  (continued)
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Fig. 3  Forest plots of breast cancer risk associated with the MTHFR A1298C polymorphism for the 
allelic (a), dominant (b), recessive (c), heterozygous (d), homozygous (e), codominant models (f)
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Fig. 3  (continued)
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Fig. 3  (continued)
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and the codominant models (OR 0.97, 95% CI 0.87–1.08, P = 0.57, I2 = 55.4%) 
(Fig. 3).
Following subgroup analyses, inter-study heterogeneity was changed among 
some of the strata. Table 2 shows more detailed results of subgroup analyses. It 
is worth noting that, in all the investigated genetic models except for the codomi-
nant mode, the participants in Western Asia were significantly associated with the 
risk of BC.
Moreover, after the step-by-step removal of the included studies, no statisti-
cal change was witnessed between pre- and post-sensitivity pooled ORs for the 
allele, the heterozygous, the homozygotes, and the codominant models. How-
ever, the pooled OR for the dominant model was sensitive to the study by Chou 
et al. (2006) (OR 1.13, 95% CI 1.02–1.26) and the pooled OR for the recessive 
model was sensitive to that of Akram et al. (2012) (OR 1.31, 95% CI 1.11–1.55) 
(Table 3).
In spite of the fact that the included studies were visually and quantitatively 
assessed, no significant evidence of publication bias was found, indicating a low risk 
of publication bias; except for the homozygous model (P Begg’s test = 0.02, P Egg-
er’s test = 0.01) (Supp 1 Fig. S7–S12). After using a nonparametric method (Duval 
and Tweedie), it was found that the summary effect size did not change before 
and after the included studies were censored to pool the association between the 
homozygous model with the risk of BC.
Discussion
BC is a multifactorial disease that is not only developed due to environmental fac-
tors but also by genetic variants that affect the expression and function of proteins. 
The MTHFR enzyme plays a very important role in folate metabolism, hence its 
involvement in the process of DNA methylation (Botezatu et al. 2013; Cheng et al. 
2012). DNA methylation may lead to suppression of tumor suppressor genes as well 
as activation of proto-oncogenes (Meneses-Sanchez et al. 2019). This is the first sys-
tematic review and meta-analysis which has incorporated a considerable number of 
studies (36 studies) on the association of RNLS MTHFR C677T and A1298C vari-
ants with susceptibility to BC among Asians. It was found that the MTHFR C677T 
polymorphism was associated with BC. Also, concurrently, this association was 
more documented through subgroup analyses in terms of ethnicity, source of con-
trol, genotyping, and agreement with HWE. In the case of A1298C polymorphism, 
allelic and homozygous models were associated with increased risk of BC; moreo-
ver, Western Asia populations showed the same association in the heterogeneous 
models which are considered as the first report in this regard.
Located in exon 4, the C677T (rs1801133) polymorphism is folate binding site of the 
MTHFR gene and affects the process of protein expression (Teng et al. 2013), thereby 
playing an important role in relation to cancers. The results of the current meta-analy-
sis study revealed that although the C677T variant, in 24,579 subjects and 36 studies, 
significantly increased the risk of BC in homozygous, recessive, dominant, and allelic 
models, no such a significant difference was found in heterozygous and overdominant 
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models. Consistent with these results, Hi and Shen in a meta-analysis study on the 
MTHFR C677T polymorphism and BC demonstrated that this variant may be a risk 
factor for BC in 14,299 Asian populations (He and Shen 2017). Despite the results 
achieved in the subgroup analyses, we could find a significant association between the 
heterozygous models with the risk of BC in participants of Eastern Asia and hospital-
based controls. Hence, it may be hypothesized that the controls and ethnicity may have 
been the source of the biased results. Furthermore, the results of the sensitivity analysis 
in this model showed that removing a study conducted by Aklizhanova et al. (2013) 
changed the pooled OR (OR 1.10, 95% CI 1.00–1.20). It has been reported that folate 
deficiency is related to aberrant DNA methylation, increased mutations, and breaks in 
chromosomes that can be associated with an enhanced risk of cancer (Choi and Mason 
2000; Tomita 2016). Interestingly, several studies have shown that the modification of 
DNA methylation by MTHFR C677T and A1298C variants may only occur under con-
ditions of limited folate content and that folate stabilizes the MTHFR C677T polymor-
phism (Del Gobbo et al. 2018). The study by Aklizhanova et al. was performed on the 
Kazakhstan population where traditional food is meat, which leads to the deficiency of 
folate, thus promoting the risk of BC development (Akilzhanova et al. 2006). Addition-
ally, they found low levels of serum folate not only in BC cases but also in normal sub-
jects, bringing about the hypothesis that low levels of serum folate in participants may 
be the possible causes of this discrepancy.
In a total of 19 studies on 15,628 subjects, it was revealed that another polymor-
phism, rs1801131 (A1298C), located in exon 7 of the MTHFR gene (Castiglia et al. 
2019), was significantly associated with BC in homozygous and allelic models, even 
though no significant difference was found in recessive, dominant, heterozygous, 
and overdominant models. Interestingly, the subgroups analysis seemed to suggest 
that genetic models of recessive, dominant, heterozygous, homozygous, and allelic 
in participants from Western Asia were significantly associated with the risk of BC. 
Additionally, a number of other studies have shown that this polymorphism was not 
significantly related to the risk of BC (Rai 2014; Zhang et al. 2016). Nonetheless, 
the results of subgroup analysis also revealed that this polymorphism was signifi-
cantly associated with the risk of BC in participants from Western Asia in all the 
investigated genetic models, except for the codominant model. Therefore, it has 
been speculated that the discrepancy between the findings was most likely due to the 
racial ethnic differences, ethnicity, patient selection criteria, sources of control, and 
sample size. A meta-analysis conducted by He and shen (2017) investigated only 
the MTHFR C677T variant, while our meta-analysis assessed both MTHFR C677T 
and A1298C SNPs. Moreover, they included 19 Asian studies and concluded no sig-
nificant association between MTHFR C677T and breast cancer among Asians. How-
ever, we included 36 Asian studies (almost twofold compared to the study by He 
and Shen (2017), indicating the association of MTHFR C677T and breast cancer. In 
addition, in the case of the A1298C variant, allelic and homozygous genetic mod-
els were associated with increased risk of BC; moreover, Western Asia populations 
showed the same association in the heterogeneous models which are considered as 
the first report in this regard.
Although this is an up-to-date meta-analysis study, there were a number of limi-
tations that need to be mentioned. First, given the high rate of heterogeneity in a 
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number of findings, it is likely that the results are negatively affected, suggesting 
further studies are required. Second, subgroup analysis was not performed according 
to the levels of serum folate. Third, this analysis was carried out only on researches 
published in English. However, the present study also had some highlights which 
include more reliable results due to the increased sample size, as well as the use of 
all the possible genetic models in examining the association between these two poly-
morphisms and the risk of BC.
Conclusion
In conclusion, the present meta-analysis showed that the MTHFR C677T variants 
might be a promising factor that predisposes BC in an Asian population. In contrast 
to other studies reporting a non-significant association between the A1298C variant 
and BC, we found that the A1298C variant acts as a risk factor for BC, particularly 
in the Western Asian population. Nevertheless, further studies are required to show 
the association of MTHFR C677T and A1298C gene polymorphisms with BC in an 
Asian population in the presence of other factors such as folate levels.
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